Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?
Belinda M. Kumpel(NHS Blood and Transplant), Christopher J. Elson(University of Bristol)
Cited by 103
Related Papers
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers
|Vox Sanguinis|2007|97
Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS
|British Journal of Haematology|1989|93